Putnam Investments »

Kiniksa Pharmaceuticals shares owned by Putnam Investments

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Putnam Investments from 13F filings

Historical chart of Putnam Investments investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Putnam Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Putnam Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $708k 41k 17.37
2023-06-30 $579k 41k 14.08
2023-03-31 $456k 42k 10.76
2022-12-31 $359k 24k 14.98

More positions owned by Putnam Investments

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Exxon Mobil Corp Common Stock (XOM)
Meta Platforms Common Stock (META)
Oracle Corp Common Stock (ORCL)
Walmart Common Stock (WMT)
Alphabet Common Stock (GOOG)
Regeneron Pharmaceuticals Common Stock (REGN)
Bank Of America Corp Common Stock (BAC)
Eli Lilly & Co Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Mckesson Corp Common Stock (MCK)
Merck & Co Common Stock (MRK)

View all positions for Putnam Investments

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals